Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,331,500
-$14,798,500 QoQ
Shares Held
150,000
-85.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 245 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. DYN ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in DYN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,331,500 | 150,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,130,000 | 1,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $101,164,320 | 5,172,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $44,958,100 | 3,554,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,378,320 | 3,191,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $45,942,000 | 1,950,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $86,314,754 | 2,402,972 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $117,445,120 | 3,328,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $66,006,750 | 2,325,000 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $1,125,000 | 100,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $6,912,000 | 600,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,636,000 | 400,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,715,000 | 450,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,915,900 | 570,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,230,000 | 750,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,189,000 | 100,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $812,000 | 50,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,104,000 | 100,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||